Conseco offering new shares at $4.73 apiece
Carmel-based insurer hopes to raise $234 million through public offering.
Health Care & Insurance
Articles
Lilly wins approval for long-acting Zyprexa
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
Dormir acquires two sleep companies
Carmel firm using $12 million in venture capital for buying spree is now nation’s second-largest operator of sleep centers.
Noble of Indiana to provide in-home services to disabled
The service will launch in February. Its goal is to serve 15 clients by June 30, 2010.
Health care reform would push state to hike Medicaid pay to docs
An actuarial report prepared by the local office of Milliman Inc., a Seattle-based consulting firm, projects
that the state of Indiana would have to hike its Medicaid payments by one-third in order to entice more
doctors into the program.
Plainfield’s MD Logistics sued by Bristol-Myers over lost insulin
Two semi-trailers of the medication were stolen in 2007 from a back lot at Daum Trucking, which isn’t named in the lawsuit.
Bristol-Myers charges MD Logistics with negligence in the $10.7 million suit.
Eli Lilly’s shares slip after it forecasts mixed profits in coming years
The Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results
could fall precipitously.
South Bend mental health facility cutting 100 jobs
The Madison Center in South Bend has notified state officials that 100 employees at the mental health facility will lose their jobs.
HealthNet lands $10.5 million in stimulus funds
HealthNet said it will use the funds to expand and renovate two community health centers that have outgrown their space.
Lilly forecasts growth in earnings next year
Eli Lilly and Co. said it still expects its earnings per share to grow in the double-digit range through 2011.
Conseco shares fall on weak profit forecast
Carmel-based insurer also wants to amend bank loans to assuage investor concerns ahead of $200 million stock offering.
Ariad asks court to restore patent-suit win against Lilly
A federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent
claim.
Health reform provision called ‘death sentence’ for doctor-owned hospitals
House and Senate versions of health care reform could halt the trend toward physician-owned hospitals.
Health care reform could drive more people to buy their own insurance
If Congress passes health care reform, more people will become like Juli Erhart-Graves, whose family spends nearly 18 percent
of its income on health insurance and out-of-pocket medical costs.
Hoosiers ‘waste’ $2.5B a year on health care, group says
Analysis of Medicare data finds that Indiana hospitals and doctors rack up higher costs to treat the same conditions as the
nation’s model markets.
Shepherd Insurance buys rival DeTrude & Co.
The acquisition of DeTrude & Co. by Shepherd Insurance marks the 13th purchase of an Indianapolis-area benefits brokerage since mid-2007.
Part of Mississippi’s Zyprexa case against Lilly dismissed
Indianapolis-based Eli Lilly and Co. has won a bid to dismiss part of a negligence lawsuit brought by Mississippi that alleges
improper marketing of antipsychotic drug Zyprexa for unapproved uses.
Lilly extends research pact with India firm
Jubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five
years.
Lilly’s Cymbalta wins new approval for anxiety disorder
FDA action should boost sales of the Eli Lilly and Co. drug, which were already on pace to top $3 billion this year.
HICKS: New breast cancer recommendation not supported
Under the current proposal, the same type of groups that made the CDC’s recommendations will outline guidelines about which treatment will be offered under a government program.